dQ&A research reveals primary care challenges in adopting diabetes tech, highlighting needs for CGM training, simpler tools, and better industry support.
Our latest Diabetes Drug Insights study follows a group of more than n=3,000 people with type 2 diabetes in the USA from 2018 to 2024.
This study explores how activity monitoring mobile apps and software impact overall health outcomes in PWT2, focusing on both physical and mental well-being.
